Safety and Tolerability of Lete-cel in NSCLC-Reply.

IF 10 1区医学 Q1 ONCOLOGY

Clinical Cancer Research Pub Date : 2025-05-01 DOI:10.1158/1078-0432.ccr-25-0070

Mehmet Altan,Gilberto Lopes,T Jeroen N Hiltermann,Ramaswamy Govindan,Liza C Villaruz,Emiliano Calvo,Martin J Edelman,Muhammad Furqan,Joel Neal,Enriqueta Felip,Jennifer W Carlisle,John V Heymach,Róisín Eilish O'Cearbhaill,Marjorie Zauderer,Michael Chisamore,Ellie Corigliano,Ioanna Eleftheriadou,Stefan Zajic,Ben Jenkins,Sophia Goodison,Sunil Suchindran,Natalia Ramos-Hernandez,Nidale Tarek,Adam J Schoenfeld

引用次数: 0

查看原文本刊更多论文

Lete-cel治疗非小细胞肺癌的安全性和耐受性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical Cancer Research 医学-肿瘤学

CiteScore

20.10

自引率

1.70%

发文量

1207

审稿时长

2.1 months

期刊介绍： Clinical Cancer Research is a journal focusing on groundbreaking research in cancer, specifically in the areas where the laboratory and the clinic intersect. Our primary interest lies in clinical trials that investigate novel treatments, accompanied by research on pharmacology, molecular alterations, and biomarkers that can predict response or resistance to these treatments. Furthermore, we prioritize laboratory and animal studies that explore new drugs and targeted agents with the potential to advance to clinical trials. We also encourage research on targetable mechanisms of cancer development, progression, and metastasis.